Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H ( (HK:6990) ) has provided an update.
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. has secured approval from the Hong Kong Stock Exchange for the dis-application of specific biotech listing rules after meeting the market capitalization and revenue thresholds for standard listings. The move reflects the company’s transition from a pre-revenue biotech issuer to a mature, profit-generating pharmaceutical player with a trading record of at least three years and substantial sales from its own drug portfolio.
With its market capitalization reaching about HKD113.6 billion as of April 8, 2026, and 2025 revenue exceeding RMB2.0 billion, including over RMB500 million from proprietary products, the company now qualifies under the Exchange’s Rule 8.05(3). From April 14, 2026, its shares will trade without the “B” marker under the new English short name “SKB BIO,” signaling strengthened fundamentals and potentially broadening its appeal to a wider base of institutional and retail investors while leaving share certificates, stock code, and trading arrangements unchanged.
The most recent analyst rating on (HK:6990) stock is a Buy with a HK$526.00 price target. To see the full list of analyst forecasts on Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H stock, see the HK:6990 Stock Forecast page.
More about Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. is a Chinese biopharmaceutical company focused on the research and development, manufacturing, and commercialization of novel drugs. Listed on the Main Board of the Hong Kong Stock Exchange since July 2023, it targets revenue-generating innovative pharmaceutical products and has rapidly grown its market capitalization and sales in both domestic and international markets.
Average Trading Volume: 534,958
Technical Sentiment Signal: Buy
Current Market Cap: HK$113.6B
For an in-depth examination of 6990 stock, go to TipRanks’ Overview page.